Skip Navigation

COVID-19 Update

We are vaccinating patients ages 12+. Learn more:

Vaccines | Testing | Patient Care | Visitor Guidelines | Coronavirus | Self-Checker |  Email Alerts

Search Menu
Gynecology & Obstetrics

In This Section      
 

Ovarian Cancer: Julie's Story

Facing ovarian cancer, Julie fought hard to regain her health — with the help of a caring surgeon and a collaborative team.

Julie Baird fishingJulie, recovering, enjoying outdoor activities. 

Julie's Story: Highlights

  • Julie Baird, a Johns Hopkins finance professional, was diagnosed with ovarian cancer that had spread to other areas.
  • Surgeon Rebecca Stone and oncologist Andrew Mener treated Julie with extensive chemotherapy and surgery, collaborating with gastrointestinal surgeons.
  • Today, Julie is clear of cancer and is on an advanced regimen to prevent a recurrence.

The pain in her lower belly had been nagging Julie Baird for over a year. It wasn’t severe, and it wasn’t constant, but Julie was looking for an explanation and some relief. Tests didn’t reveal any problems, but the pain didn’t go away.

Then, one weekend in October 2017, things escalated. Julie recalls, “I was having severe chest pains when I’d bend over. I went to the emergency room and doctors found that I had fluid around my left lung. After other tests, they said I needed to be admitted.

“Lesions on my liver and other places is what they said.”

A Diagnosis of Ovarian Cancer, and a Plan

While she was in the hospital, Julie underwent a series of tests. The results brought the diagnosis: cancer in both ovaries, which had spread to Julie’s lower abdomen.

The news was devastating. Her husband had died years earlier, and she couldn’t imagine her two daughters having to face the loss of their other parent. “I was in a pretty dark place,” she admits.

Julie’s oncologist recommended the Kelly Gynecologic Oncology Service group. Julie didn’t have to wait long to connect with her new doctor, Rebecca Lynn Stone, M.D., M.S. Stone called Julie at home on a Sunday, and assured her that she had a plan.

Stone explains: “In treating ovarian cancer, sometimes we do surgery first, followed by chemotherapy. In other situations, like Julie’s, when the cancer has spread to certain areas, we use a ‘sandwich’ approach: chemo, then surgery, then chemo.”

Testing and Treating the Ovarian Tumor

Together, Julie and Stone swung into action. A biopsy showed that the cancer was growing on the outer layers of Julie’s ovaries and spreading to other organs. This level of cancer is classified as stage 4a. Genetic testing of the cancer revealed the cells had a mutation that meant Julie had a good chance of responding to treatment.

Julie would undergo three three-week rounds of chemotherapy to shrink the tumors before surgery. She enlisted friends and family to help, delegated everything she could, and plunged into the regimen.

It wasn’t easy. “Nausea was tough,” she says, “and after the first nine weeks I needed medications to support my blood cells and a transfusion. But we only had to delay the chemo for one week.”

When Julie lost her hair in December, she and her daughters got an assortment of crazy wigs, and wore them.

“You have to find humor where you can,” Julie laughs.

Julie Baird family photoJulie and her family enjoying the outdoors.

The ‘Big’ Surgery

On February 7, 2018, Julie underwent 10 hours of surgery. The team removed all of Julie’s reproductive organs and small areas of cancer from her stomach and liver. Stone didn’t work alone. A gastrointestinal surgeon helped to remove Julie’s gallbladder, spleen and omentum, a curtain of tissue that covers the abdominal organs — and can provide a hiding place for cancer cells.

In addition, two sections of her colon were removed, requiring an ileostomy—a surgical opening in the intestine connected to a bag worn outside the body to collect waste.

Stone explains: “Sometimes, imaging will show us all the areas that need to be treated, and we’ll work on the surgical plan with surgeons in other specialties, such as thoracic (chest), endocrine (glands) or hepatobiliary (liver). Other times, we can discover the involvement of other areas once we’re in the operating room, and call in other specialists at the last minute.

“Either way, the Weinberg surgical center is a collaborative environment. All of us have trained at major cancer centers and are used to working together successfully.”

Stone called Julie’s daughters and told them she and her team had gotten it all.

“This was big surgery, but I got amazing care at The Johns Hopkins Hospital,” Julie says. “Dr. Stone is just stellar."

Dr. Stone is a great surgeon and a great woman. She saved my life.

- Julie Baird

More Treatment to Avoid Recurrence

The test of Julie’s spiritual strength wasn’t over. After a long recovery from surgery, she had to start another nine weeks of chemo, and it was harder this time. She needed several blood transfusions. Her platelets dipped. She developed blood clots in her lungs and legs, requiring the placement of a filter in her inferior vena cava — a major vein that carries blood from the lower and middle portions of the body into the heart.

Seven weeks into the nine-week chemotherapy course, Julie’s oncologist, Andrew Scott Mener, M.D., let her off early as a result of these complications. Her ileostomy was reversed in June, and the vein filter was removed in August. She had already returned to her full-time job at Johns Hopkins the month before.

To lower the risk of this particular cancer returning, Julie’s oncologist and Stone prescribed olaparib, a PARP inhibitor. PARP inhibitors are drugs that prevent cancer cell DNA from repairing itself, causing the cells to die. Olaparib was approved in December 2018 by the FDA for treating first bouts of cancer.

Stone notes that Julie will probably take the PARP inhibitor for the rest of her life. “PARP inhibitors have the potential to cut cancer off at the knees, using biology.”

Julie says, “My first big scan in December 2018 came back clean.”

Julie Baird holding grandsonJulie and her new grandson.

Celebrating New Life

Julie says she’s relied on her faith and her positive attitude throughout her illness and recovery. “At one point I asked [Stone’s] team if they were praying people, if they believed in some kind of higher power, since I’m a faith-based person, and they were all open to that.”

These days she opts for cleaner, more organic foods, and cares for her body and soul through mindfulness practices, yoga, staying in the moment as much as possible and getting a good night’s sleep.

Now that she’s stronger, Julie says going through cancer has only increased her resiliency, which she’s glad to share. She joined the same peer mentoring program that supported her, walking with other women who are navigating the ups and downs of cancer and its treatment.

Spring 2019 brought Julie another reason to celebrate her new lease on life: Her first grandson was born on March 9.

Julie is grateful to Johns Hopkins and the surgeon who had a plan from the start. “Dr. Stone is a great surgeon and a great woman. She saved my life.”

Meet Julie’s Surgeon

Learn more about our team of gynecologic oncologists.

About Ovarian Cancer

Dr Fader with patient

Ovarian cancer can arise from three different types of cells in the ovary: epithelial cells that cover the surface of the ovary; germ cells that make the eggs in the ovary and stromal cells within the ovary that produce female hormones.

Learn more about ovarian cancer.

Ovarian Cancer Treatment at Johns Hopkins

Gynecologic Oncology teamSurgeons of the Johns Hopkins Division of Gynecologic Oncology


The Kelly Gynecologic Oncology Service brings together award-winning surgeons and other leaders in diagnosis and treatment of tumors affecting the female reproductive tract. The group works as a partner with the Ovarian Cancer Center of Excellence at the Sidney Kimmel Comprehensive Cancer Center. Combining expertise in medical, radiologic and surgical approaches, the team offers patients a range of treatments, informed by innovative research and administered with compassion and skill.